Insider sells 5,332 PTCT shares for $391K

Lee S. Golden reported sales of common stock under Rule 144.

Rhea-AI Filing Summary

Lee S. Golden reported sales of common stock under Rule 144. The filing shows sales of 1,340 shares on 01/06/2026 for $103,109.78, 642 shares on 01/07/2026 for $49,744.60, 866 shares on 01/08/2026 for $66,204.92, and 2,484 shares on 02/18/2026 for $172,281.80.

The filing also lists multiple prior restricted stock vesting entries issued by the company on various dates, including vesting quantities such as 1,287 on 01/09/2023 and 1,885 on 01/05/2024, shown as background to the sold securities.

Insights

Corporate Governance Analyst

Routine insider dispositions reported under Rule 144; amounts and dates are explicit.

The filing itemizes four open-market Rule 144 sales by Lee S. Golden, listing exact share counts and gross proceeds for each trade: $103,109.78, $49,744.60, $66,204.92, and $172,281.80.

These transactions appear as individual dispositions with no additional qualifiers in the excerpt; subsequent filings would be required to show any continuing dispositions or changes in beneficial ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What shares did Lee S. Golden sell according to the PTCT Form 144?

Lee S. Golden sold 1,340; 642; 866; and 2,484 common shares on specified dates. The filing lists proceeds of $103,109.78, $49,744.60, $66,204.92, and $172,281.80 for those respective trades.

Are the sale dates and proceeds disclosed in the PTCT filing?

Yes; the filing lists trade dates and gross proceeds for each disposition. Trades occurred on 01/06/2026, 01/07/2026, 01/08/2026, and 02/18/2026 with the proceeds shown per sale.

Does the Form 144 show why the shares were available to sell for PTCT?

The filing includes multiple prior restricted stock vesting entries issued by the company on various dates. Vesting quantities and dates are listed, indicating the source of transferable shares prior to the reported sales.

Does this Form 144 change PTCT's reported beneficial ownership significantly?

The filing records specific dispositions by one reporting person only. It does not provide complete post-sale beneficial ownership percentages or outstanding share totals in the excerpt, so ownership impact cannot be determined from this excerpt alone.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/05/2026 - 11:16 AM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001686217
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PTC THERAPEUTICS, INC.
SEC File Number	001-35969
Address of Issuer	500 WARREN CORPORATE CENTER DRIVE WARREN NEW JERSEY 07059
Phone	9082227000
Name of Person for Whose Account the Securities are To Be Sold	Golden Lee Scott
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	10000	633800.00	82774730	03/05/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/31/2020	Restricted Stock Vesting	Issuer			227	12/31/2020	Compensation
Common	05/04/2021	Restricted Stock Vesting	Issuer			526	05/04/2021	Compensation
Common	06/30/2021	Restricted Stock Vesting	Issuer			206	06/30/2021	Compensation
Common	12/31/2021	Restricted Stock Vesting	Issuer			285	12/31/2021	Compensation
Common	01/06/2022	Restricted Stock Vesting	Issuer			696	01/06/2022	Compensation
Common	05/04/2022	Restricted Stock Vesting	Issuer			540	05/04/2022	Compensation
Common	06/30/2022	Restricted Stock Vesting	Issuer			293	06/30/2022	Compensation
Common	12/30/2022	Restricted Stock Vesting	Issuer			298	12/30/2022	Compensation
Common	01/06/2023	Restricted Stock Vesting	Issuer			712	01/06/2023	Compensation
Common	01/09/2023	Restricted Stock Vesting	Issuer			1287	01/09/2023	Compensation
Common	01/10/2023	Restricted Stock Vesting	Issuer			1328	01/10/2023	Compensation
Common	05/04/2023	Restricted Stock Vesting	Issuer			538	05/04/2023	Compensation
Common	06/30/2023	Restricted Stock Vesting	Issuer			327	06/30/2023	Compensation
Common	12/29/2023	Restricted Stock Vesting	Issuer			301	12/29/2023	Compensation
Common	01/05/2024	Restricted Stock Vesting	Issuer			1885	01/05/2024	Compensation
Common	01/06/2024	Restricted Stock Vesting	Issuer			551	01/06/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Lee S. Golden 500 Warren Corporate Center Drive Warren NJ 07059	Common	01/06/2026	1340	103109.78
Lee S. Golden 500 Warren Corporate Center Drive Warren NJ 07059	Common	01/07/2026	642	49744.60
Lee S. Golden 500 Warren Corporate Center Drive Warren NJ 07059	Common	01/08/2026	866	66204.92
Lee S. Golden 500 Warren Corporate Center Drive Warren NJ 07059	Common	02/18/2026	2484	172281.80

144: Remarks and Signature

Remarks
Date of Notice	03/05/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/04/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Lee Golden
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)